HomeACHV • NASDAQ
Achieve Life Sciences Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 12.19M | 177.93% |
Net income | -12.36M | -125.71% |
Net profit margin | — | — |
Earnings per share | -0.36 | -38.46% |
EBITDA | -12.13M | -180.25% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 34.36M | 121.02% |
Total assets | 38.63M | 99.44% |
Total liabilities | 17.73M | -14.82% |
Total equity | 20.90M | — |
Shares outstanding | 34.69M | — |
Price to book | 4.25 | — |
Return on assets | -70.42% | — |
Return on capital | -84.56% | — |
Cash Flow
Net Change in Cash
Net change in cash
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Net income | -12.36M | -125.71% |
Cash from operations | -9.19M | -110.56% |
Cash from investing | 11.72M | 195,383.33% |
Cash from financing | 682.00K | — |
Net change in cash | 3.21M | 173.38% |
Free cash flow | -5.98M | -131.61% |
Previous close
$2.55
Day range
$2.38 - $2.53
Year range
$2.38 - $5.59
Market cap
83.94M USD
Avg Volume
160.42K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
1991
Headquarters
Website
Employees
25